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The present work describes the serum haptoglobin (Hp) dynamics in piglets vaccinated and non-vaccinated with a
commercial porcine circovirus type 2 (PCV2) vaccine at 3 weeks of age, and its relationship with the average daily
weight gain (ADWG). The field study was carried out on two farms (A and B) with a previous clinical history of
PCV2-systemic disease (PCV2-SD). The aim of the study was to assess whether Hp could be used as a surrogate
marker of PCV2 vaccine efficacy. PCV2 infection was confirmed by quantitative real time PCR (qPCR) in pigs from
both farms, but PCV2-SD was only diagnosed in farm A. No statistically significant relation was found between
serum Hp concentration and the percentage of qPCR positive animals and the treatment applied (PCV2 vaccination)
in both farms. On the other hand, using linear regression analysis, a significant negative correlation between the
area under the curve of Hp (AUCHp) and ADWG was observed for farm A (p < 0.00001) and B (p = 0.01). Based on
the obtained determination coefficient (R2) values, AUCHp explained 20.0 and 11.6% of the observed ADWG for
farms A and B, respectively. The present study supports that the measurement of acute phase proteins may be an
indicator of ADWG in pig farms, but it was not apparently feasible to use the serum Hp concentration as a
surrogate marker of PCV2 vaccine efficacy.
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Porcine circovirus type 2 (PCV2)-systemic disease
(PCV2-SD, formerly known as postweaning multisyste-
mic wasting syndrome, PMWS), a disease primarily
caused by PCV2, is considered one of the major swine
diseases worldwide [1]. Traditionally, its control was
based on counteracting the risk or triggering factors
associated to this pathological condition, such as manage-
ment improvement, control of co-infections and changes
of the boar genetic background [2,3]. However, com-
mercial PCV2 vaccines available during the last 7 years
have demonstrated to be very efficient to control
PCV2-SD and PCV2 subclinical infection under nat-
ural conditions, as well as to improve production* Correspondence: joaquim.segales@cresa.uab.cat
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unless otherwise stated.parameters such as average daily weight gain (ADWG)
and mortality [4-8].
Acute phase proteins (APPs) are a group of blood
proteins that change their concentration in animals sub-
jected to external or internal challenges such as infection,
inflammation, surgical trauma or stress [9,10]. After the
challenge, there is an increase in the plasma concentration
of the so-called positive APPs, such as haptoglobin (Hp),
Pig major acute-phase protein (Pig-MAP), serum amyl-
oid A and C-reactive protein. On the other hand, other
protein concentrations decrease, such as albumin,
which represent the negative APPs. It has also been sug-
gested that serum APPs may be used as an index for
monitoring ADWG. In particular, low serum positive
APPs have been correlated with better production pa-
rameters in pigs [11-13].
The aim of the present study was to describe the evolu-
tion of Hp serum levels in a population of pigs vaccinated
and non-vaccinated against PCV2 and assess whether Hphis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 2 Haptoglobin serum concentration (±SEM) at the
different sampling times in fifty vaccinated (V) and fifty
non-vaccinated (NV) pigs with a PCV2 vaccine at 3 weeks of
age for farm B. A clinical outbreak of colibacillosis and clinical signs
of porcine respiratory disease complex were recorded at 10 and
23 weeks of age, respectively. No PCV2-SD was diagnosed in farm B.
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efficacy.
Results and discussion
Hp dynamics in serum samples from vaccinated and
non-vaccinated pigs in farms A and B are shown in
Figures 1 and 2, respectively.
Virological results of this study have been described in
Fraile et al. [5]. Briefly, PCV2 in serum samples was ab-
sent (farm B) or with prevalence lower than 5% (farm A)
until 14 weeks of age. Subsequently, both PCV2 preva-
lence and viral load increased progressively in both
vaccinated and control groups, reaching a maximum
prevalence at 17 and 20 weeks of age in farms A and B,
respectively. In both farms, the percentage of qPCR
positive pigs was significantly lower in vaccinated
animals compared to non-vaccinated ones for several
sampling periods throughout the trial [5]. Vaccinated
animals in farm A showed lower mean serum Hp con-
centration than controls during the period of higher per-
centage of PCV2 qPCR positive animals (17 weeks of
age, [5]). However, no statistically significant relation
was found between serum Hp concentration and the
percentage of qPCR positive animals and the treatment
(PCV2 vaccination) in both farms. Moreover, no statistical
relation was observed between AUCHp and AUCPCV2 for
farm B but it was observed a statistical tendency (p = 0.07
and correlation coefficient of 0.19) for this relation in farm
A. On the other hand, using linear regression analysis,
a significant negative correlation between AUCHp and
ADWG was observed for farms A (p < 0.00001) and B
(p = 0.01). Based on the determination coefficient (R2)
values obtained, AUCHp explained 20 and 11.6% of the3 6 10 14 17 20 23
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Figure 1 Haptoglobin serum concentration (±SEM) at the
different sampling times in fifty vaccinated (V) and fifty
non-vaccinated (NV) pigs with a PCV2 vaccine at 3 weeks of
age for farm A. PCV2-SD was diagnosed around 12 weeks of age
by means of clinical signs, histopathological findings and
detection of PCV2 in tissues.observed ADWG for farms A and B, respectively.
When data from both farms were analysed together,
serum Hp concentration was significantly different taking
into account farm and period of sampling as explanatory
variables, whereas treatment effect was not significantly
different, and only a statistical interaction (sampling time
and treatment) was found for farm A.
It could be considered surprising that no significant
differences were detected between the Hp serum concen-
tration between vaccinated and non-vaccinated animals
around PCV2 vaccination. The administration of a vaccine
is considered an immunological systemic challenge for
the animal, especially when administered intramuscu-
larly. However, the specific product characteristics of
the vaccine used indicate possible increase in rectal
temperature up to 1.4°C (rarely higher than 2.5°C), last-
ing less than 24 hours [14]. Therefore, since the first
blood sampling took place just before vaccination and
the following one was 3 weeks post-vaccination, there
were no real chances to detect an elevation of Hp due to
vaccination.
Serum Hp concentration profiles were different de-
pending on the farm tested in the present study. Clinical
signs potentially compatible with PCV2-SD, character-
ized by growth retardation and increased mortality, were
mainly observed around 2 months after vaccination in
both farms (A and B), about 11–12 weeks of age. At that
time it was observed a Hp serum concentration in pigs
above a published reference value for this protein
(0.9 mg/dL, [15]) in both farms, independently of the
treatment applied. However, PCV2-SD was only con-
firmed by means of laboratory analyses in farm A [5].
According to the results, serum Hp concentration may
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PCV2-SD diagnosis (farm A), mostly during the period
of maximum prevalence of PCV2 infection but not in
case of non-clinical/subclinical presentation (farm B).
Since PCV2-SD is a chronic disease, usually associated
with concurrent infections, it is very likely that the more
persistent increased levels of Hp in farm A (Figure 1)
would be related with this complex disease scenario. Im-
portantly, an outbreak of colibacillosis and clinical signs
of porcine respiratory disease complex were recorded at
10 and 23 weeks of age, respectively, in farm B. Accord-
ingly, Hp serum concentration above 0.9 mg/dL (reference
threshold in pigs) was also observed around those ages in
this particular farm. Since the release pattern of this APP
could vary in each farm due to the presence of different
infectious and non-infectious factors, it was suggested that
the two “peaks” of Hp observed in farm B (Figure 2), could
apparently be associated to the presence of digestive and
respiratory problems. As expected, these non-PCV2 asso-
ciated clinical signs affected similarly to both PCV2 vacci-
nated and non-vaccinated animals.
The present study shows that the measurement of
APPs may be an indicator of ADWG in pig farms.
Specifically, lower Hp serum concentrations measured
throughout the growing and fattening periods of the pigs
(calculated as AUCHp) were significantly correlated with
improvement of production parameters (ADWG). These
results are in agreement with published data that indi-
cates a relationship between Hp serum levels and
ADWG in pigs younger than 13 weeks old [12,16], and
also during the critical phase of post-weaning growth
and adult pigs [11,13]. Moreover, Hp was also found to
be negatively correlated with growth rate in pigs fed a
diet supplemented with β-glucans as growth promoter
[17]. The APP response by itself may contribute to dif-
ferences in ADWG since it has been suggested that, in
diseased animals or even after vaccination, aminoacids
may be diverted from muscle protein synthesis to APPs
synthesis [18].
Conclusions
It was not apparently feasible to use the serum Hp
concentration pattern as a surrogate marker of PCV2
vaccine efficacy. This was probably due to the fact that
an increase of Hp could be due to many factors not re-
lated with PCV2 infection dynamics or the effect of
PCV2 vaccination. Obtained results fit with a previous
work in which the increase of APP levels depended on
the development of PCV2-SD at individual basis and not
on infection with PCV2 at a subclinical level [19].
Methods
Two farms (A and B), located in North-Eastern Spain,
were selected based on their clinical history of PCV2-SDto evaluate the efficacy of an inactivated PCV2 vaccine
licensed for piglets. Details of this field study have
already been thoroughly described [5]. Briefly, from a
total of 1,239 pigs, 619 of them received a single dose of
0.5 mL of CIRCOVAC® at 3 weeks of age whereas 620
received the same amount of phosphate buffer solution
(non-vaccinated animals). A subpopulation of 50 pigs
from each group (vaccinated and non-vaccinated) in
each farm were bled at 3, 6, 10, 14, 17, 20, 23 and
26 weeks of age. In the case of farm A, sampling was
not carried out at 26 weeks of age because the bleeding
at 23 weeks of age was close to the first shipment of
pigs to the slaughterhouse. PCV2 load was investigated
by means of a real-time quantitative PCR (qPCR) as
previously described [20], and ADWG was also calcu-
lated for each individual pig [5].
Serum was obtained by centrifugation and frozen
at −20°C until assaying. Hp was quantified by using
a spectrophotometric method (hemoglobin binding
assay) with commercial reagents from Tridelta Develop-
ment Limited (Ireland), and performed on an automated
analyzer (Olympus AU400, Hamburg, Germany). The
intra-assay and inter-assay coefficient of variations were
determined as previously described [21]. Detection limit
was 0.05 mg/ml for Hp as indicated by the manufacturer.
All statistical analyses were carried out using the SAS
system V.9.1.3 (SAS institute Inc, Cary, NC, USA). For
all analyses, the individual pig was used as the experimen-
tal unit. The significance level (α) was set at 0.05. Area
under the curve of Hp (AUCHp) and the area under the
curve for PCV2 viral load (AUCPCV2) versus time were
calculated by the trapezoidal rule for each individual pig.
A linear regression analysis was carried out to assess the
strength of relation between AUCHp and AUCPCV2 for
farms A and B. This same statistical tool was used to esti-
mate the strength of relation between ADWG and the
AUCHp. Finally, GLM and MIXED model procedures of
SAS system V.9.1.3 with repeated measures statement
were used to analyze the effect of independent variables
(Xi): farm, PCV2 vaccination (treatment) and sampling
period, and their interactions with Hp serum concentra-
tion (y dependent variable).
The experimental procedure was approved by the
Ethical and Animal Welfare Committee of the Universitat
Autònoma of Barcelona (Reference 665M2).
Competing interests
This study was funded by Merial Laboratories, Spain. AC is employed by
Merial Laboratories, Spain.
Authors’ contributions
AB and YS carried out the haptoglobin determination and drafted the
manuscript. MS and LGR carried out the PCV2 PCR and drafted the
manuscript. AC, SLS and MN participated in the design of the study,
performed the statistical analysis and drafted the manuscript. LF and JS
conceived the study, participated in its design and coordination and helped
to draft the manuscript. All authors read and approved the final manuscript.
Fraile et al. Porcine Health Management 2015, 1:3 Page 4 of 4
http://www.porcinehealthmanagement.com/content/1/1/3Authors’ information
LF, SL, MN and JS are ECPHM diplomates.
Acknowledgements
The authors thank the invaluable help during sampling of the animals and
sample processing from CReSA (Anna Llorens, Gerard Martín, Meritxell
Simon, Rosa López and Mónica Pérez).
Author details
1Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la
Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès),
Barcelona, Spain. 2Departament de Producció Animal, ETSEA, Universitat de
Lleida, 25198 Lleida, Spain. 3Servei de Bioquímica Clínica Veterinària,
Departament de Bioquímica i Biologia Molecular, Facultat de Veterinària,
Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès),
Barcelona, Spain. 4Departament de Sanitat i Anatomia Animals, Universitat
Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Barcelona,
Spain. 5Merial Laboratories, Barcelona, Spain.
Received: 8 July 2014 Accepted: 23 October 2014
Published: 16 April 2015
References
1. Grau-Roma L, Fraile L, Segalés J. Recent advances in the epidemiology,
diagnosis and control of diseases caused by porcine circovirus type 2. Vet J.
2011;187:23–32.
2. López-Soria S, Nofrarías M, Calsamiglia M, Espinal A, Valero O, Ramirez-Mendoza
H, et al. Post-weaning multisystemic wasting syndrome (PMWS) clinical
expression under field conditions is modulated by the pig genetic
background. Vet Microbiol. 2011;149:352–7.
3. Madec F, Eveno E, Morvan P, Hamon L, Blanchard P, Cariolet R.
Post-weaning multisystemic wasting syndrome (PMWS) in pigs in France:
clinical observations from follow-up studies on affected farms. Livest
Prod Sci. 2000;63:223–33.
4. Fachinger V, Bischoff R, Jedidia SB, Saalmuller A, Elbers K. The effect of
vaccination against porcine circovirus type 2 in pigs suffering from porcine
respiratory disease complex. Vaccine. 2008;26:1488–99.
5. Fraile L, Grau-Roma L, Sarasola P, Sinovas N, Nofrarías M, López-Jimenez R,
et al. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets:
improvement of production parameters and interaction with maternally
derived immunity. Vaccine. 2012;30:1986–92.
6. Kixmöller M, Ritzmann M, Eddicks M, Saalmüller A, Elbers K, Fachinger V.
Reduction of PMWS-associated clinical signs and co-infections by
vaccination against PCV2. Vaccine. 2008;26:3443–51.
7. Kristensen CS, Baadsgaard NP, Toft N. A meta-analysis comparing the effect
of PCV2 vaccines on average daily weight gain and mortality rate in pigs
from weaning to slaughter. Prev Vet Med. 2011;98:250–8.
8. Segalés J, Urniza A, Alegre A, Bru T, Crisci E, Nofrarías M, et al. A genetically
engineered chimeric vaccine against porcine circovirus type 2 (PCV2)
improves clinical, pathological and virological outcomes in postweaning
multisystemic wasting syndrome affected farms. Vaccine. 2009;27:7313–21.
9. Eckersall PD, Bell R. Acute phase proteins: Biomarkers of infection and
inflammation in veterinary medicine. Vet J. 2010;185:23–7.
10. Murata H, Shimada N, Yoshioka M. Current research on acute phase
proteins in veterinary diagnosis: an overview. Vet J. 2004;168:28–40.
11. Clapperton M, Bishop SC, Glass EJ. Innate immune traits differ between
Meishan and Large White pigs. Vet Immunol Immunopathol.
2005;104:131–44.
12. Eurell TE, Bane DP, Hall WF, Schaeffer DJ. Serum haptoglobin concentration
as an indicator of weight gain in pigs. Can J Vet Res. 1992;56:6–9.
13. Piñeiro C, Piñeiro M, Morales J, Carpintero R, Campbell FM, Eckersall PD,
et al. Pig acute-phase protein levels after stress induced by changes in the
pattern of food administration. Animal. 2007;1:133–9.
14. EPAR Circovac® Vaccine. In: http://www.ema.europa.eu/docs/en_GB/
document_library/EPAR_-_Product_Information/veterinary/000114/
WC500061517.pdf.
15. Piñeiro C, Piñeiro M, Morales J, Andrés M, Lorenzo E, Pozo MD, et al.
Pig-MAP and haptoglobin concentration reference values in swine from
commercial farms. Vet J. 2009;179(1):78–84.
16. Grellner GF, Fangman TJ, Carroll JA, Wiedmeyer CE. Using serology in
combination with acute phase proteins and cortisol to determine stress andimmune function of early-weaned pigs. J Swine Health Prod.
2002;10:199–204.
17. Hiss S, Sauerwein H. Influence of dietary β-glucan on growth performance,
lymphocyte proliferation, specific immune response and haptoglobin
plasma concentrations in pigs. J Anim Physiol Anim Nutr. 2003;87:2–11.
18. Gruys E, Toussaint MJ, Upragarin N, Van EA, Adewuyi AA, Candiani D, et al.
Acute phase reactants, challenge in the near future of animal production
and veterinary medicine. J Zhejiang Univ Sci. 2005;B 6:941–7.
19. Segalés J, Piñeiro C, Lampreave F, Nofrarías M, Mateu E, Calsamigli M, et al.
Haptoglobin and pig-major acute protein are increased in pigs with
postweaning multisystemic wasting syndrome (PMWS). Vet Res.
2004;35:275–82.
20. Olvera A, Sibila M, Calsamiglia M, Segalés J, Domingo M. Comparison of
porcine circovirus type 2 load in serum quantified by a real time PCR in
postweaning multisystemic wasting syndrome and porcine dermatitis and
nephropathy syndrome naturally affected pigs. J Virol Methods.
2004;117:75–80.
21. Saco Y, Fraile L, Giménez M, Pato R, Montoya M, Bassols A. Haptoglobin
serum concentration is a suitable biomarker to assess the efficacy of a feed
additive in pigs. Animal. 2010;4:1561–7.
doi:10.1186/2055-5660-1-3
Cite this article as: Fraile et al.: Serum haptoglobin dynamics in pigs
vaccinated or not vaccinated against porcine circovirus type 2. Porcine
Health Management 2015 1:3.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
